- Home
- THRD vs MCFT Comparison
THRD vs MCFT Comparison
Compare THRD & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- MCFT
- Stock Information
- Founded
- THRD 2019
- MCFT 1968
- Country
- THRD United States
- MCFT United States
- Employees
- THRD N/A
- MCFT N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- MCFT Marine Transportation
- Sector
- THRD Health Care
- MCFT Industrials
- Exchange
- THRD Nasdaq
- MCFT Nasdaq
- Market Cap
- THRD 157.7M
- MCFT 286.5M
- IPO Year
- THRD 2022
- MCFT 2015
- Fundamental
- Price
- THRD $3.45
- MCFT $17.17
- Analyst Decision
- THRD Buy
- MCFT Buy
- Analyst Count
- THRD 3
- MCFT 4
- Target Price
- THRD $14.00
- MCFT $20.50
- AVG Volume (30 Days)
- THRD 435.5K
- MCFT 69.7K
- Earning Date
- THRD 03-25-2025
- MCFT 05-07-2025
- Dividend Yield
- THRD N/A
- MCFT N/A
- EPS Growth
- THRD N/A
- MCFT N/A
- EPS
- THRD N/A
- MCFT N/A
- Revenue
- THRD N/A
- MCFT $311,260,000.00
- Revenue This Year
- THRD N/A
- MCFT N/A
- Revenue Next Year
- THRD N/A
- MCFT $20.29
- P/E Ratio
- THRD N/A
- MCFT N/A
- Revenue Growth
- THRD N/A
- MCFT N/A
- 52 Week Low
- THRD $3.18
- MCFT $16.12
- 52 Week High
- THRD $16.94
- MCFT $24.05
- Technical
- Relative Strength Index (RSI)
- THRD 30.03
- MCFT 41.31
- Support Level
- THRD $3.36
- MCFT $16.47
- Resistance Level
- THRD $3.65
- MCFT $18.39
- Average True Range (ATR)
- THRD 0.14
- MCFT 0.68
- MACD
- THRD 0.16
- MCFT -0.03
- Stochastic Oscillator
- THRD 35.48
- MCFT 31.11
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.